Miller Edward

CIK 00016192522 companiesCHESHIRE, CT

SEC Profile

Transactions

Companies

Filings

CIK

0001619252

Recent Transactions

50 trades

Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2025-02-21$10.08/sh−106→ 6,517 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2025-01-23$9.45/sh−47→ 6,628 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2025-01-23$9.94/sh−5→ 6,623 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2025-01-10$0.44/sh−409→ 153,541 total
Gift
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-12-11+57,549→ 346,348 total
Gift
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-12-11−57,549→ 153,950 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-11-19$0.55/sh−432→ 211,499 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-11-05$0.86/sh−2,272→ 211,931 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-10-22$0.77/sh−766→ 214,203 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-10-21$0.78/sh−635→ 214,969 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-10-03$0.81/sh−377→ 215,604 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-08-19$0.76/sh−422→ 215,981 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-08-05$0.73/sh−2,323→ 216,403 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-07-22$0.74/sh−757→ 218,726 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-07-19$0.75/sh−634→ 219,483 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-07-02$0.72/sh−379→ 220,117 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-05-17$0.75/sh−420→ 220,496 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-05-03$0.80/sh−2,311→ 220,916 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-04-22$0.75/sh−757→ 223,227 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-04-19$0.75/sh−626→ 223,984 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-04-02$0.77/sh−368→ 224,610 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-02-20$0.70/sh−385→ 224,978 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-02-05$0.67/sh−8,869→ 225,363 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-01-23$0.67/sh−1,302→ 234,232 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-01-04$0.64/sh−424→ 235,534 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-02-02+87,500→ 235,958 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2023-02-02+162,500→ 497,844 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-01-20$5.14/sh−541→ 148,458 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-01-19$5.08/sh−2,032→ 148,999 total
Gift
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-12-02+98,346→ 288,799 total
Gift
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-12-02−98,346→ 151,031 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-11-14$8.91/sh−2,358→ 190,453 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-10-20$9.36/sh−553→ 249,377 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-10-19$9.36/sh−553→ 249,377 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-08-16+15,000→ 249,930 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2022-07-01+26,000→ 26,000 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-07-01+14,000→ 234,930 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-01-18+23,256→ 217,307 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2022-01-18+56,744→ 56,744 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-01$38.58/sh−3,800→ 195,011 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-03-01$39.14/sh−2,200→ 192,811 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-01-19+28,000→ 194,051 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2021-01-19+52,000→ 52,000 total
Gift
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2020-12-01−41,514→ 166,051 total
Gift
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2020-12-01+41,514→ 198,811 total
Conversion
Kalaris Therapeutics, Inc.$KLRS
Series B Convertible Preferred Stock
2020-08-03−48,819→ 0 total
Conversion
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2020-08-03+32,759→ 32,759 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2020-07-29+200,600→ 200,600 total
Sale
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2017-02-28$131.70/sh−330→ 14,884 total
Award
ALEXION PHARMACEUTICALS, INC.
Common Stock, par value $.0001 per share
2017-02-28+4,400→ 19,284 total

Companies

Recent Filings

Address

C/O ALEXION PHARMACEUTICALS, INC. 352 KNOTTER DRIVE

CHESHIRE, CT, 06410

View on SEC.gov